임원ㆍ주요주주특정증권등거래계획보고서
Received: 7/24/2026 · Reporter: HLB생명과학
HLB제약의 임원과 주요주주는 2026년 7월 24일 특정 증권 거래 계획을 보고하였으며, 이는 지분변동을 알리는 공시입니다.
🏢 Past 12 months filing pattern (this company)
- Total filings
- 30 filings
- Same category
- 9 filings
- Previous same-category filing
- 7/22/2026(2 days ago)
- Corrections / withdrawals
- 1 filing
Filing source / License
The original PDF/HTML of this filing is provided by FSS DART. MarketBubbles displays only metadata (title, receipt number, type, reporter) and a rule-based summary; we do not mirror the original PDF body (per FSS ToS).